Androgenetic alopecia (AGA) is a hair loss disorder affecting 80% of men and 50% of women throughout their lifetime. Therapies for AGA are limited and there is no cure. There is a high demand for hair restoration. Platelet-rich plasma (PRP), a treatment modality shown to promote wound healing, has also been explored as a treatment for AGA. This literature review was conducted to assess the effectiveness of PRP treatment for AGA. Twelve studies conducted from 2011 to 2017 were evaluated and summarized by study characteristics, mode of preparation, and treatment protocols. A total of 295 subjects were given PRP or control treatment in these studies, and evaluated for terminal hair density, hair quality, anagen/telogen hair ratio, keratinocyte proliferation, blood vessel density, etc. Some studies also provided subject self-assessment reports. Most of the studies reviewed showed effectiveness of PRP in increasing terminal hair density/diameter. Additional investigations are needed to determine the optimal treatment regimen for high efficacy of PRP in AGA.

Keywords:
Platelet-rich plasma, Androgenetic alopecia, Androgenic alopecia, Hair disorder, Hair follicle, Hair growth, Growth factors
1.
Piraccini BM, Alessandrini A: Androgenetic alopecia. G Ital Dermatol Venereol 2014;149:15-24.
2.
Varothai S, Bergfeld WF: Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol 2014;15:217-230.
3.
Bae JM, Jung HM, Goo B, Park YM: Hair regrowth through wound healing process after ablative fractional laser treatment in a murine model. Lasers Surg Med 2015;47:433-440.
4.
Stefanato CM: Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 2010;56:24-38.
5.
Cranwell W, Sinclair R: Male androgenetic alopecia; in De Groot LJ, Chrousos G, Dungan K, et al (eds): Endotext. MDText, South Dartmouth, 2000.
6.
McElwee KJ, Shapiro JS: Promising therapies for treating and/or preventing androgenic alopecia. Skin Therapy Lett 2012;17:1-4
7.
Agarwal S, Godse K, Mahajan A, Patil S, Nadkarni N: Application of the basic and specific classification on patterned hair loss in Indians. Int J Trichology 2013;5:126-131.
8.
Gupta M, Mysore V: Classifications of patterned hair loss: a review. J Cutan Aesthet Surg 2016;9:3-12.
9.
Dinh QQ, Sinclair R: Female pattern hair loss: current treatment concepts. Clin Interv Aging 2007;2:189-199.
10.
Olsen EA: Disorders of Hair Growth: Diagnosis and Treatment, ed 2. McGraw-Hill, New York, 2003.
11.
Adil A, Godwin M: The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol DOI 10.1016/j.jaad.2017.02.054.
12.
Singhal P, Agarwal S, Dhot PS, Sayal SK: Efficacy of platelet-rich plasma in treatment of androgenic alopecia. Asian J Transfus Sci 2015;9:159-162.
13.
Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA: Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 2014;15:115-127.
14.
Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR: Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 2014;46:144-151.
15.
Afifi L, Maranda EL, Zarei M, Delcanto GM, Falto-Aizpurua L, Kluijfhout WP, Jimenez JJ: Low-level laser therapy as a treatment for androgenetic alopecia. Lasers Surg Med DOI 10.1002/lsm.22512.
16.
Marwah M, Godse K, Patil S, Nadkarni N: Is there sufficient research data to use platelet-rich plasma in dermatology? Int J Trichology 2014;6:35-36.
17.
Dhillon RS, Schwarz EM, Maloney MD: Platelet-rich plasma therapy - future or trend? Arthritis Res Ther 2012;14:219.
18.
Oh DS, Cheon YW, Jeon YR, Lew DH: Activated platelet-rich plasma improves fat graft survival in nude mice: a pilot study. Dermatol Surg 2011;37:619-625.
19.
Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA: Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012;28:429-439.
20.
Dhurat R, Sukesh M: Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg 2014;7:189-197.
21.
Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P, Inchingolo F, Sammartino G, Rasmusson L, Evert PA: In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol 2012;13:1131-1137.
22.
Denton EG, Shaffer JA, Alcantara C, Clemow L, Brondolo E: Hispanic residential ethnic density and depression in post-acute coronary syndrome patients: re-thinking the role of social support. Int J Soc Psychiatry 2015;61:225-235.
23.
Maria-Angeliki G, Alexandros-Efstratios K, Dimitris R, Konstantinos K: Platelet-rich plasma as a potential treatment for noncicatricial alopecias. Int J Trichology 2015;7:54-63.
24.
Giusti I, Rughetti A, D'Ascenzo S, Millimaggi D, Pavan A, Dell'Orso L, Dolo V: Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion 2009;49:771-778.
25.
Akiyama M, Smith LT, Holbrook KA: Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol 1996;106:391-396.
26.
Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y, Rinaldi F: A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol 2013;169:690-694.
27.
Gkini M-A, Kouskoukis A-E, Tripsianis G, Rigopoulos D, Kouskoukis K: Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through a one-year period. J Cutan Aesthet Surg 2014;7:213-219.
28.
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, Orlandi A, Gentile P: The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014;2014:760709.
29.
Anitua E, Pino A, Martinez N, Orive G, Berridi D: The effect of plasma rich in growth factors on pattern hair loss: a pilot study. Dermatol Surg 2017;43:658-670.
30.
Puig CJ, Reese R, Peters M: Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg 2016;42:1243-1247.
31.
Mapar MA, Shahriari S, Haghighizadeh MH: Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial. J Cosmet Laser Ther 2016;18:452-455.
32.
Gupta S, Revathi TN, Sacchidanand S, Nataraj HV: A study of the efficacy of platelet-rich plasma in the treatment of androgenetic alopecia in males. Indian J Dermatol Venereol Leprol 2017;83:412.
33.
Alves R, Grimalt R: Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg 2016;42:491-497.
34.
Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V: The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med 2015;4:1317-1323.
35.
Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N: Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg 2014;7:107-110.
36.
Schiavone G, Raskovic D, Greco J, Abeni D: Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg 2014;40:1010-1019.
37.
Takikawa M, Nakamura S, Nakamura S, Ishirara M, Kishimoto S, Sasaki K, Yanagibayashi S, Azuma R, Yamamoto N, Kiyosawa T: Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011;37:1721-1729.
38.
Sanchez AR, Sheridan PJ, Kupp LI: Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93-103.
39.
Marx RE: Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10:225-228.
40.
Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K: Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7:213-219.
41.
Hillmann K, Garcia Bartels N, Kottner J, Stroux A, Canfield D, Blume-Peytavi U: A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men. Skin Pharmacol Physiol 2015;28:236-244.
42.
Dhurat R, Saraogi P: Hair evaluation methods: merits and demerits. Int J Trichology 2009;1:108-119.
43.
Lee EH, Kang JS, Kang DS, Han CS, Oh SH, Cho SB: Facilitated scalp measuring using phototrichogram with a headband and tapeline. Dermatol Surg 2011;37:1150-1152.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.